Introduction: Inflatable penile prosthesis (IPP) is commonly performed in a hospital or ambulatory setting which involves overnight stay. However, recent literature has demonstrated that IPP surgery is increasingly being performed as same-day procedures in outpatient settings with patients not requiring overnight stay. Objective: We sought to investigate the rate of complications following day surgery insertion of an IPP. The following was collected within six weeks of their procedure, 1. infection, 2. hospital admission, 3. emergency/urgent care visits, and 4. additional prescription for analgesia. Methods: A prospective study is being performed since March 2023 of all patients undergoing day surgery insertion of an IPP at Men's Health Clinic Manitoba (MHC). MHC is an outpatient ambulatory surgical centre. Only patients that are classified as ASA 1 or 2 and suitable for day surgery are deemed eligible for surgery at MHC. Patients are enrolled and consented on the day of the procedure. Patients were prescribed Bactrim BS BID two days prior to surgery along with a Dexedin/Hibiclens wash. Vancomycin and Gentamycin were given pre-operatively. Intraoperative Irricept wash was used during the case for irrigation and implant prep. All procedures involved a three-piece prosthetic device and were performed under spinal anesthesia with an infrapubic approach, with patients discharged with a catheter and a drain. Post-operatively, Gabapentin, Celebrex and Tylenol were given for analgesia. Results: Currently, 15 patients are enrolled in this study with a mean patient age +/- SD of 64.3 +/- 8.2 years. All procedures were performed successfully with no intra-operative complications. The mean procedure length defined as time from of incision to when the dressing is placed on the surgical wound was 70.7 +/- 19.8 minutes. The mean post-operative duration of stay defined as patient entry into post-operative recovery room to time they leave the clinic was 135.6 +/- 78.8 minutes. Patients were cleared for device after six weeks. Thus far, no patients have required hospital admission or emergency room visits, nor have there been any documented cases of post-operative infection. 20% of the patients have required additional post-operative analgesia (n=3). Conclusions: This study will aim to evaluate whether outpatient IPP implantation can yield a similar complication risk to those performed in an inpatient hospital setting. If successful, our findings could help increase accessibility and reduce wait times for patients as they could avoid limited hospital operating room use. Disclosure: Any of the authors act as a consultant, employee or shareholder of an industry for: Boston Scientific. [ABSTRACT FROM AUTHOR]